Yuan Shi
Fudan University
33 Papers
102 Citations
Yuan Shi is an academic researcher from Fudan University. The author has contributed to research in topics: Medicine & Aneurysm. The author has an hindex of 8, co-authored 21 publications.
Chat about Author
Papers
PIK3C2A is a gene-specific target of microRNA-518a-5p in imatinib mesylate-resistant gastrointestinal stromal tumor
Yuan Shi,Xiaodong Gao,Qin Hu,Xiaojing Li,Jian-Fang Xu,Shaohua Lu,Yalan Liu,Chen Xu,Dongxian Jiang,Jiaqian Lin,Anwei Xue,Yunshan Tan,Kuntang Shen,Yingyong Hou +13 more
TL;DR: Low expression of miR-518a-5p is likely to upregulate PIK3C2A and affect the cellular response to the drug, causing resistance to imatinib in GISTs.
34
Stage and histological grade of gastrointestinal stromal tumors based on a new approach are strongly associated with clinical behaviors.
TL;DR: It was found that the clinical stage and grade were strongly associated with prognosis and patients in clinical stage II were of the highest degree of malignancy regardless of the number of parameters.
24
MiR-320a downregulation is associated with imatinib resistance in gastrointestinal stromal tumors
Xiaodong Gao,Kuntang Shen,Cui-zhong Wang,Jiaqian Ling,Hongshan Wang,Yong Fang,Yuan Shi,Yingyong Hou,Jin Qin,Yihong Sun,Xinyu Qin +10 more
TL;DR: It was found that low expression of miR-320a was correlated with short time to imatinib resistance, and the potential mechanism of miRs320a for imatinIB resistance was proposed.
23
Prognostic impact and potential interaction of EGFR and c-Met in the progression of esophageal squamous cell carcinoma
Haixing Wang,Dongxian Jiang,Song Qi,Chen Xu,Yuan Shi,Xiaojing Li,Jie Huang,Yifan Xu,Akesu Sujie,Haiying Zeng,Yun-Shi Zhong,Lijie Tan,Yingyong Hou +12 more
TL;DR: Examination of EGFR and c-Met variation in precancerous lesion, early esophageal squamous cell carcinoma (ESCC), and advanced ESCC finds they might be involved in the tumorigenesis and development of ESCC and has different prognostic significance in patients with differing c- met expression status.
13
Subsequent intra-abdominal fibromatosis mimicking recurrent gastrointestinal stromal tumor
Dongxian Jiang,Deming He,Yingyong Hou,Weiqi Lu,Yuan Shi,Qin Hu,Shaohua Lu,Chen Xu,Yalan Liu,Ju Liu,Yunshan Tan,Xiong-zeng Zhu +11 more
TL;DR: Although intra-abdominal fibromatosis subsequent to GIST is very rare, it is of clinical significance in imatinib era as an influencing factor for making clinical decision.